BR9806210A - Processos de contracepção masculina e para terapia de substituição de androgênio, contraceptivo masculino, e, forma de dosagem para a terapia de substituição de androgênio. - Google Patents

Processos de contracepção masculina e para terapia de substituição de androgênio, contraceptivo masculino, e, forma de dosagem para a terapia de substituição de androgênio.

Info

Publication number
BR9806210A
BR9806210A BR9806210-7A BR9806210A BR9806210A BR 9806210 A BR9806210 A BR 9806210A BR 9806210 A BR9806210 A BR 9806210A BR 9806210 A BR9806210 A BR 9806210A
Authority
BR
Brazil
Prior art keywords
processes
replacement therapy
male
androgen replacement
dosage form
Prior art date
Application number
BR9806210-7A
Other languages
English (en)
Inventor
Alfred J Moo-Young
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Publication of BR9806210A publication Critical patent/BR9806210A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

"PROCESSOS DE CONTRACEPçãO MASCULINA E PARA TERAPIA DE SUBSTITUIçãO DE ANDROGêNIO, CONTRACEPTIVO MASCULINO, E, FORMA DE DOSAGEM PARA A TERAPIA DE SUBSTITUIçãO DE ANDROGêNIO". A presente invenção diz respeito a processos para prover a contracepção masculina usando -se um androgênio especificado sem a necessidade de um agente esterilizante separado. A invenção também descreve processos para substituição de androgênio não-contraceptivo e dispositivos úteis para realizar ambos os processos.
BR9806210-7A 1997-09-17 1998-09-17 Processos de contracepção masculina e para terapia de substituição de androgênio, contraceptivo masculino, e, forma de dosagem para a terapia de substituição de androgênio. BR9806210A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US5930097P 1997-09-17 1997-09-17
US6296297P 1997-10-10 1997-10-10
US09/154,283 US6767902B2 (en) 1997-09-17 1998-09-16 Androgen as a male contraceptive and non-contraceptive androgen replacement
PCT/US1998/019402 WO1999013883A1 (en) 1997-09-17 1998-09-17 Androgen as a male contraceptive and non-contraceptive androgen replacement

Publications (1)

Publication Number Publication Date
BR9806210A true BR9806210A (pt) 2000-04-18

Family

ID=27369621

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9806210-7A BR9806210A (pt) 1997-09-17 1998-09-17 Processos de contracepção masculina e para terapia de substituição de androgênio, contraceptivo masculino, e, forma de dosagem para a terapia de substituição de androgênio.

Country Status (6)

Country Link
US (2) US6767902B2 (pt)
EP (1) EP0966288A4 (pt)
JP (1) JP2001505589A (pt)
BR (1) BR9806210A (pt)
CA (1) CA2271657C (pt)
WO (1) WO1999013883A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
DE10233723A1 (de) * 2002-07-24 2004-02-12 Schering Ag Mikrobiologische Verfahren zur Herstellung von 7α-substituierten 11α-Hydroxysteroiden, daraus herstellbare 7α,17α-substituierte 11β-Halogensteroide, deren Herstellungsverfahren und Verwendung sowie pharmazeutische Präparate, die diese Verbindungen enthalten, sowie daraus herstellbare 7α-substituierte Estra-1,3,5(10)-triene
CN100339486C (zh) 2002-07-24 2007-09-26 舍林股份公司 制备7α－被取代的11α－羟基甾族化合物的微生物方法
JO2492B1 (en) 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
CN102145005A (zh) * 2006-02-01 2011-08-10 杨百翰大学 阳离子类固醇抗微生物剂组合物及其使用方法
MX2013010749A (es) 2011-03-22 2013-10-17 Population Council Inc Regeneracion de mielina con androgenos.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177267A (en) 1963-12-09 1979-12-04 Crown Zellerbach Enhancing tissue penetration of physiologically active steroidal agents with DMSC
AU565354B2 (en) 1983-11-14 1987-09-10 Bio-Mimetics Inc. Bioadhesive compositions and methods of treatment therewith
US4573996A (en) 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
US4788218A (en) * 1984-05-21 1988-11-29 Sri International 17 a β-hydroxy-7 α-methyl-d-homo-19-norandrost-4,16-diene-3-one and the 17-esters thereof: methods of preparation and uses
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5342834A (en) 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation
EP0500287B1 (en) 1991-02-20 1995-04-26 Hitachi, Ltd. Catalyzer control apparatus
US5332576A (en) 1991-02-27 1994-07-26 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
CA2075517C (en) 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
AU678237B2 (en) 1993-04-20 1997-05-22 Hexal Pharma Gmbh Active substance-containing plaster
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US5733565A (en) 1996-02-23 1998-03-31 The Population Council, Center For Biomedical Research Male contraceptive implant

Also Published As

Publication number Publication date
US20040132698A1 (en) 2004-07-08
EP0966288A1 (en) 1999-12-29
JP2001505589A (ja) 2001-04-24
US20020193359A1 (en) 2002-12-19
CA2271657A1 (en) 1999-03-25
WO1999013883A1 (en) 1999-03-25
EP0966288A4 (en) 2004-11-10
CA2271657C (en) 2007-08-07
US6767902B2 (en) 2004-07-27

Similar Documents

Publication Publication Date Title
BG101553A (en) Progesterone antagonist and antiestrogenous active compounds of general application for female contraceptives
DE60141145D1 (pt)
HK1037861A1 (en) Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention
BR0016708A (pt) Forma de dosagem de droga baseada em hidrogel
BR9710198A (pt) Contraceptivo oral constituìdo por combinação farmacêutica de estrogênio-androgênio-progestina.
BR0113067A (pt) Forma de dosagem de drogas à base de hidrogel
PT954314E (pt) Formas de dosagem farmaceutica para melhorar a disfuncao erectil masculina
BR9813982A (pt) Anticoncepcionais orais contendo antiestrogênio mais progestina
PT1079790E (pt) Utilizacao de composicoes microbicidas e espermicidas para inactivacao de virus sem envelope
IL166432A0 (en) Composition containing an androgenous 11?-halogen steroid and a progestational hormone and male contraceptive based on said composition
MX9701946A (es) Solucion oftalmica transportadora.
BR9712892A (pt) Dispositivo vaginal, e, processo para fornecer proteção contra gravidez ou doenca sexualmente transmissìvel, ou ambos.
BR9806210A (pt) Processos de contracepção masculina e para terapia de substituição de androgênio, contraceptivo masculino, e, forma de dosagem para a terapia de substituição de androgênio.
BG102682A (en) System for the release of contraceptives having bactericidal and/or antiviral effect
NZ502495A (en) Use of a specific antagonist of 5HT2 receptor antagonist for the preparation of medicines useful in the treatment of sleep apnoea syndrome
DE69521122D1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze
BR9814136A (pt) Conjunto contraceptivo, processos de fabricação do mesmo e de tratamento de sangramento, usos de anti-progestogênio, de progestogênio e de anti-progestogênio, e, de um composto.
MXPA01011296A (es) Composiciones contraceptivas que contienen derivados de indolina y agentes progestacionales.
BG106534A (en) Oral solution containing galanthamine and a sweetening agent
WO1996028154A3 (de) Verwendung von antiestrogenen zur männlichen fertilitätskontrolle
NO975790L (no) Anvendelse av allylaminderivater slik som terbinafin, i fremstillingen av et medikament for behandling av helikobacterpylori-infeksjonsassosierte sykdommer
HUP0301790A2 (hu) Spermium-, baktérium- és vírusölż hatással rendelkezż kémiai készítmény és a hüvelycsatornába történż bejuttatására szolgáló segédeszköz
JPH0810304Y2 (ja) コンドーム
PT1365768E (pt) Utilização de antagonistas selectivos para er-beta como contraceptivos
BR9809435A (pt) Sais farmaceuticamente aceitáveis de 3-sulfato de 5alfa-pregnan-3beta, 16alfa-diol-20-ona úteis como progestinas e distúrbios do snc

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI.